MedTrace Logo

Real-World Data Study to Understand Effectiveness of Treatments in Peyronie's Disease

NCT05873595 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 29

Last updated 2024-04-16

No results posted yet for this study

Summary

This is an observational study, meaning participants will not receive any investigational treatment as part of this study.

Researchers will collect real-world data (RWD) to gain a more in-depth knowledge of the treatment of Peyronie's Disease (PD) to evaluate the management of PD.

Conditions

  • Peyronie's Disease

Sponsors & Collaborators

  • Endo Pharmaceuticals

    lead INDUSTRY

Principal Investigators

  • Medical Information · Endo Pharmaceuticals

Eligibility

Min Age
18 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-06-20
Primary Completion
2024-02-26
Completion
2024-02-26

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05873595 on ClinicalTrials.gov